共 50 条
- [3] N-PHOSPHONACETYL-L-ASPARTATE (PALA), PHASE-I TRIAL [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 200 - 200
- [4] PHASE-I TRIAL OF PALA (N-PHOSPHONACETYL-L-ASPARTATE) [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 314 - 314
- [5] COMPETITIVE PROTEIN-BINDING ASSAY FOR N-PHOSPHONACETYL-L-ASPARTATE (PALA) [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 185 - 185
- [7] AN OVERVIEW OF THE CLINICAL-PHARMACOLOGY OF N-PHOSPHONACETYL-L-ASPARTATE (PALA), A NEW ANTIMETABOLITE [J]. RECENT RESULTS IN CANCER RESEARCH, 1980, 74 : 65 - 71
- [8] CENTRAL NERVOUS-SYSTEM (CNS) TOXICITY OF PALA (N-PHOSPHONACETYL-L-ASPARTATE) [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 350 - 350
- [9] MECHANISMS OF SENSITIVITY OR RESISTANCE OF MURINE TUMORS TO N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) [J]. CANCER TREATMENT REPORTS, 1979, 63 (08): : 1291 - 1302
- [10] NUCLEOTIDE LEVELS IN TUMOR-CELLS AND XENOGRAFTS TREATED WITH COMBINATION DIPYRIDAMOLE (DP) AND N-PHOSPHONACETYL-L-ASPARTATE (PALA) [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 244 - 244